(240 days)
The OrthoPAT™ Orthopedic Perioperative Autotransfusion System is intended for use in major orthopedic surgical procedures, such as joint replacement or spinal fusion to salvage red blood cells lost during and after surgery. It processes the shed blood to separate and wash the red blood cells (RBCs) and make them available for autologous transfusion to the patient.
The OrthoPAT™ system consists of a single-use disposable set and an electromechanical device. The patient's blood is contained within the disposable set, is used for both intraoperative and postoperative processing (concentration and washing) of shed blood. The concentrated red blood cells are deposited into a bag. The bag is removed from the OrthoPAT system prior to the blood being reinfused.
The electromechanical device controls the collection process, the separation and washing process and the flow of fluids through the disposable. It contains a centrifige, a pneumatic system, a valve system, electronic circuitry, a rechargeable battery, software for monitoring and controlling the operation of the system, and a separately-mounted display panel with a control keypad.
The system is compact, light weight, can be mounted on an IV pole or bed frame, and is designed to follow the patient from the operating room, to the recovery room, and, if necessary, to the hospital floor. The on-board rechargeable battery provides power to the system to maintain suction while the patient is being transported. The system functions automatically without a dedicated operator.
The provided document is a 510(k) Summary of Safety and Effectiveness for the OrthoPAT™ Perioperative Autotransfusion System. It details the device's description, intended use, and claims of substantial equivalence to predicate devices, supported by performance data.
Here's an analysis of the acceptance criteria and study information provided in the document:
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria | Reported Device Performance (OrthoPAT™ System) |
|---|---|
| Total cell recovery | Ranged from 79% to 88% |
| Washout efficiency of contaminants | Ranged from 95% to 100% |
2. Sample Size Used for the Test Set and Data Provenance
- Sample Size: The document does not explicitly state the sample size (number of runs or tests) used for the in vitro simulation. It refers to "an in vitro simulation of use test."
- Data Provenance: The study was an "in vitro simulation of use test," meaning it was conducted in a lab setting, not on human subjects. The country of origin of the data is not specified, but the submitter is based in Natick, MA, USA. The study is prospective in nature, as it simulates future use of the device.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not provided in the document. For an in vitro simulation of a medical device, "ground truth" would typically be established by established laboratory measurement standards and protocols, not necessarily expert consensus from medical professionals in the same way it would be for diagnostic imaging.
4. Adjudication Method for the Test Set
This information is not applicable and not provided. The performance data presented (total cell recovery, washout efficiency) are objective, quantitative measurements derived from the in vitro tests, not subjective interpretations requiring adjudication.
5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done
No, an MRMC comparative effectiveness study was not done. The document focuses on demonstrating substantial equivalence through in vitro performance data, not by comparing human reader performance with and without AI assistance.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Yes, the performance data provided is for the device operating in a standalone manner (in vitro simulation). The reported metrics (cell recovery, washout efficiency) reflect the device's inherent capability to process blood without direct human intervention impacting these specific performance parameters during the processing phase. The device is designed to function automatically without a dedicated operator.
7. The Type of Ground Truth Used
For the in vitro simulation, the ground truth would be based on:
- Established laboratory measurement standards: The percentage of total cell recovery and washout efficiency would be measured using validated analytical methods.
- Reference materials: Known concentrations of red blood cells and contaminants would be used in the simulated blood input, allowing for a precise calculation of recovery and removal rates.
8. The Sample Size for the Training Set
This information is not applicable. The OrthoPAT™ system is a mechanical and electromechanical device with software for control, not a machine learning or AI-based diagnostic tool that requires a "training set" in the conventional sense of supervised learning algorithms. Its design and performance are based on engineering principles and in vitro testing.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable for the reasons stated in point 8.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo for Transfusion Technologies. The logo consists of a geometric design on the left and the words "TRANSFUSION TECHNOLOGIES" on the right. The word "TRANSFUSION" is on the top line, and the word "TECHNOLOGIES" is on the bottom line.
Transfusion Technologies Corporation ▪ 9 Erie Drive ▪ Natick, MA 017ο0-1312 Tel 508-655-2277 ▪ Fax 508-655-2292
FEB 2 0 1997
ﺍﻟﻤﺴﺘﻘﻠﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘ
510(k) Summary of Safety and Effectiveness
OrthoPATTM1 Perioperative Autotransfusion System K962475
Submitter:
Transfusion Technologies Corporation 9 Erie Drive Natick, MA 02760
(508) 655-2277 (phone) (508) 655-2292 (fax)
Contact person: John J. Sokolowski
Date Prepared:
October 28, 1996
Device Name:
Classification name: Autotransfusion Apparatus
Proprietary Name: OrthoPAT™ Perioperative Autotransfusion System
Predicate Devices:
The OrthoPAT Perioperative Autotransfusion System is substantially equivalent to the Electromedics PAT 500 Portable Autotransfusion System (K910238), the IBM Model 2991 Blood Cell Processor (K812355), and the Solco-Basle Solcotrans® SI Orthopedic Autotransfusion Set (K913177).
1 OrthoPAT is a trademark of Transfusion Technologies Corporation
{1}------------------------------------------------
Device Description:
The OrthoPAT™ system consists of a single-use disposable set and an electromechanical device. The patient's blood is contained within the disposable set, is used for both intraoperative and postoperative processing (concentration and washing) of shed blood. The concentrated red blood cells are deposited into a bag. The bag is removed from the OrthoPAT system prior to the blood being reinfused.
The electromechanical device controls the collection process, the separation and washing process and the flow of fluids through the disposable. It contains a centrifige, a pneumatic system, a valve system, electronic circuitry, a rechargeable battery, software for monitoring and controlling the operation of the system, and a separately-mounted display panel with a control keypad.
The system is compact, light weight, can be mounted on an IV pole or bed frame, and is designed to follow the patient from the operating room, to the recovery room, and, if necessary, to the hospital floor. The on-board rechargeable battery provides power to the system to maintain suction while the patient is being transported. The system functions automatically without a dedicated operator.
Intended Use:
The OrthoPAT™ Orthopedic Perioperative Autotransfusion System is intended for use in major orthopedic surgical procedures, such as joint replacement or spinal fusion to salvage red blood cells lost during and after surgery. It processes the shed blood to separate and wash the red blood cells (RBCs) and make them available for autologous transfusion to the patient.
Basis for Claim of Substantial Equivalence:
Transfusion Technologies Corporation claims its Orthopedic Perioperative Autotransfusion System to be substantially equivalent to the Electromedics PAT 500 Portable Autotransfusion System (K910238), the IBM Model 2991 Blood Cell Processor (K812355), and the Solco-Basle Solcotrans® SI Orthopedic Autotransfusion Set (K913177) based on the following:
Intended Use
The OrthoPAT system and the Electromedics PAT 500 system are intended to collect and concentrate shed blood lost during surgery. The OrthoPAT system and the Solco-Bashe system are intended to collect and reinfuse blood lost postoperatively.
{2}------------------------------------------------
Design
The OrthoPAT system and the Electromedics PAT 500 system are a combination of hardware, software and sterile disposables.
In both systems, the shed blood is stored in a sterile collection reservoir until the blood is processed. The red blood cells are concentrated by centrifugation and stored in a bag for subsequent reinfusion to the patient.
The materials used in the disposable sets of both systems are well accepted in the industry for this application
The OrthoPAT system does not utilize air to move fluids within the disposable set, and therefore does not require an air sensor to detect the end of an emptying cycle. In addition, a variable volume rotor moves fluid through the disposable set by way of an elastic diaphragm. which expands and contracts by external air pressure or vacuum. This design eliminates the need for a peristaltic pump. The movement of fluid by an elastic diaphragm is substantially equivalent to the flexible membrane used by the IBM Model 2991.
Performance data
An in vitro simulation of use test of the OrthoPAT system demonstrated the quality of blood product produced by it. Total cell recovery ranged from 79% to 88%. Washout efficiency of contaminants ranged from 95% to 100%. This performance is substantially equivalent to the Electromedics PAT 500 system.
§ 868.5830 Autotransfusion apparatus.
(a)
Identification. An autotransfusion apparatus is a device used to collect and reinfuse the blood lost by a patient due to surgery or trauma.(b)
Classification. Class II (performance standards).